Valve Disease, Heart
23
8
9
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 23 trials
100.0%
+13.5% vs benchmark
13%
3 trials in Phase 3/4
29%
2 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (23)
Hummingbird ICE Study
Observational Study of Patients Undergoing Diagnostic Right Heart Catheterization
Medtronic Cardiac Surgery PMCF Registry
Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation
Apixaban VS Warfarin in AF Pts First Three Months After Repair or BIO AVR MVR
Mosaic Mitral Valve: Long-Term Outcomes in Patients Under 65
Valvular Heart Disease in Women Registry
Prospective Evaluation for Hybrid Cardiac Procedures
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
The Asia-Pacific Mitral & Tricuspid Valve-in-Valve/Valve-in-Ring Registry (AP ViV Registry)
Influence of High Vitamin C Dose on Lactate During and After Extracorporeal Circulation
Philips Intracardiac Echocardiography (ICE) Clinical Registry
Allogeneic Valve Transplantation
Cardiac Interventional ICE Imaging Trial
Del Nido Versus HTK Cardioplegia in Adult Aortic Valve Replacement
RecoveryPlus Telerehab Platform Pilot Study
The ENDOCARDITIS AUMC Data Collection
Assessment of Strength Outcomes After Use of the PrimusRS for Specificity of Training in a Cardiac Rehabilitation Setting
Early Resistance Training Post Valve Replacement Surgery
E-health Intervention for Cardiac Rehabilitation